Elijah Li Wang, Garrett W Thrash, Riyaz Razi, Yifei Sun, Keith McGregor, Prasad Shirvalkar, Harrison C Walker, Christopher J Earley, Marshall T Holland
{"title":"Spinal Cord Stimulation Effects on Restless Legs Syndrome: A Single-Center Experience.","authors":"Elijah Li Wang, Garrett W Thrash, Riyaz Razi, Yifei Sun, Keith McGregor, Prasad Shirvalkar, Harrison C Walker, Christopher J Earley, Marshall T Holland","doi":"10.1159/000553453","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Restless legs syndrome (RLS) is a lifelong disorder characterized by recurrent, uncomfortable sensations and irresistible urges to move the legs that peak in the evening. Spinal cord stimulation (SCS) is a longstanding neuromodulation treatment for chronic neuropathic pain with emerging evidence of potential effectiveness toward RLS through a potential shared pathophysiology of central sensitization.</p><p><strong>Methods: </strong>A retrospective review of our institution's electronic health record system was performed to identify patients who received SCS for chronic pain with a concomitant RLS diagnosis. Patients who had a diagnosis of RLS in their chart were secondarily confirmed to have RLS using the Cambridge-Hopkins RLS Questionnaire via telephone. The International Restless Leg Syndrome (IRLSS) Study Group Rating Scale and multiple Patient-Recorded Outcomes Measurements System (NIH PROMIS) of sleep data were obtained via telephone with patients recalling their symptoms pre- and post-SCS implantation.</p><p><strong>Results: </strong>A group of 11 patients with an existing SCS system implanted for chronic pain and comorbid RLS confirmed on the Cambridge-Hopkins questionnaire were identified. The IRLS summed score showed a statistically significant (p = 0.0343) improvement with a large effect size (r = 0.64) indicating that overall symptom severity measured by the IRLS scale decreased significantly with SCS. There was also a significant (p = 0.0223) reduction with a large effect size (r = 0.69) in the summed NIH PROMIS sleep-related impairment scores, suggesting that SCS had a substantial positive impact on sleep-related impairments. Contrary to this, insignificant (p = 0.778) changes were observed in the summed NIH PROMIS sleep disturbance scores with a small effect size (r = 0.09).</p><p><strong>Conclusion: </strong>SCS has been shown to be an effective, novel treatment for chronic pain but also has positive effects on medication refractory RLS. While this small, retrospective study is limited by recall bias, it provides further evidence of SCS serendipitously improving RLS symptoms. Future prospective research evaluating the effects of SCS on RLS symptoms, pathophysiology, and sleep is needed to further evaluate this phenomenon.</p>","PeriodicalId":22078,"journal":{"name":"Stereotactic and Functional Neurosurgery","volume":" ","pages":"1-12"},"PeriodicalIF":2.1000,"publicationDate":"2026-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stereotactic and Functional Neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000553453","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROIMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Restless legs syndrome (RLS) is a lifelong disorder characterized by recurrent, uncomfortable sensations and irresistible urges to move the legs that peak in the evening. Spinal cord stimulation (SCS) is a longstanding neuromodulation treatment for chronic neuropathic pain with emerging evidence of potential effectiveness toward RLS through a potential shared pathophysiology of central sensitization.
Methods: A retrospective review of our institution's electronic health record system was performed to identify patients who received SCS for chronic pain with a concomitant RLS diagnosis. Patients who had a diagnosis of RLS in their chart were secondarily confirmed to have RLS using the Cambridge-Hopkins RLS Questionnaire via telephone. The International Restless Leg Syndrome (IRLSS) Study Group Rating Scale and multiple Patient-Recorded Outcomes Measurements System (NIH PROMIS) of sleep data were obtained via telephone with patients recalling their symptoms pre- and post-SCS implantation.
Results: A group of 11 patients with an existing SCS system implanted for chronic pain and comorbid RLS confirmed on the Cambridge-Hopkins questionnaire were identified. The IRLS summed score showed a statistically significant (p = 0.0343) improvement with a large effect size (r = 0.64) indicating that overall symptom severity measured by the IRLS scale decreased significantly with SCS. There was also a significant (p = 0.0223) reduction with a large effect size (r = 0.69) in the summed NIH PROMIS sleep-related impairment scores, suggesting that SCS had a substantial positive impact on sleep-related impairments. Contrary to this, insignificant (p = 0.778) changes were observed in the summed NIH PROMIS sleep disturbance scores with a small effect size (r = 0.09).
Conclusion: SCS has been shown to be an effective, novel treatment for chronic pain but also has positive effects on medication refractory RLS. While this small, retrospective study is limited by recall bias, it provides further evidence of SCS serendipitously improving RLS symptoms. Future prospective research evaluating the effects of SCS on RLS symptoms, pathophysiology, and sleep is needed to further evaluate this phenomenon.
期刊介绍:
''Stereotactic and Functional Neurosurgery'' provides a single source for the reader to keep abreast of developments in the most rapidly advancing subspecialty within neurosurgery. Technological advances in computer-assisted surgery, robotics, imaging and neurophysiology are being applied to clinical problems with ever-increasing rapidity in stereotaxis more than any other field, providing opportunities for new approaches to surgical and radiotherapeutic management of diseases of the brain, spinal cord, and spine. Issues feature advances in the use of deep-brain stimulation, imaging-guided techniques in stereotactic biopsy and craniotomy, stereotactic radiosurgery, and stereotactically implanted and guided radiotherapeutics and biologicals in the treatment of functional and movement disorders, brain tumors, and other diseases of the brain. Background information from basic science laboratories related to such clinical advances provides the reader with an overall perspective of this field. Proceedings and abstracts from many of the key international meetings furnish an overview of this specialty available nowhere else. ''Stereotactic and Functional Neurosurgery'' meets the information needs of both investigators and clinicians in this rapidly advancing field.